Replies to post #5582 on Amarin Corp Plc (AMRN)

[ziploc_1]

As a retail investor,I am interested in the long term and the product, not just whether the stock is in play...That is why, I am excited about...<<Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that it has completed dosing and pharmacokinetic sampling in a study to test a fixed-dose combination of Vascepa® (icosapent ethyl) capsules and a leading statin. The clinical name for this combination product is AMR 102>>.... On a daily basis I need to take(among other meds)four capsules of Vascepa plus one Lipitor. Like many older people, I eagerly anticipate AMR 102 to reduce the number of meds I take.